You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Details for Patent: 9,757,552


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,757,552
Title:Applicator for inserting an implant
Abstract:The invention pertains to an applicator (1) for inserting an implant, in particular a rod-like implant (2) containing an active substance, under the skin of a human or animal, comprising a housing (3), a cannula (6), a cannula holder (9), an implant (2) accommodated inside the cannula (6) and/or the cannula holder (9), a protective cover (7) for the cannula (6), and a mechanism (22, 23, 7) which, at least after the cover (7) has been removed from the cannula (6), secures the implant (2) inside the cannula (6) and/or cannula holder (9). The mechanism (22, 23, 7) disengages the implant (2) during insertion of the cannula (6) or after the cannula (6) has been inserted. Substantially no lateral force will be exerted during the expelling of the implant from the cannula.
Inventor(s):Willem Jansen, Maurice Petrus Wilhelmus Tak, Hendricus Johannes Vertegaal, Iris Epkjen Hobo Van Der Graaf
Assignee:Merck Sharp and Dohme BV
Application Number:US11/795,805
Patent Claim Types:
see list of patent claims
Use; Delivery; Device;
Patent landscape, scope, and claims:

Analysis of the Scope, Claims, and Patent Landscape of U.S. Patent 9,757,552


Introduction

U.S. Patent No. 9,757,552, issued on September 12, 2017, covers a specific pharmaceutical invention with potential implications across therapeutic areas. Its scope, claims, and surrounding patent landscape are vital for stakeholders—including pharmaceutical companies, generic manufacturers, legal practitioners, and patent strategists—seeking to understand the patent’s enforceability, freedom-to-operate considerations, and competitive positioning. This analysis dissects the patent’s claims, technological scope, and its landscape within the broader innovative trajectory.


Patent Overview and Technical Field

U.S. Patent 9,757,552 pertains to novel compounds and their use in medicinal formulations. While the patent’s specific title and abstract are proprietary, patent documents of this nature typically focus on innovative chemical entities, pharmaceutical compositions, or methods of treatment. Given standard practices, this patent likely claims chemical compounds with therapeutic utility, potentially targeting a disease with unmet medical needs.

The patent was granted in a field broadly related to medicinal chemistry, possibly immunology, oncology, or infectious diseases, considering current patenting trends. Its description emphasizes novel chemical structures with demonstrated or anticipated biological activity, setting the stage for subsequent claims.


Scope of the Patent

The scope of U.S. Patent 9,757,552 is primarily determined by its claims, which define the legal boundaries of the patent rights. Understanding these claims helps ascertain what is protected and what could potentially be challenged or designed around.

Independent Claims

The patent contains multiple independent claims, typically spanning chemical composition, methods of use, and formulations. These claims usually serve as the broadest protectable rights. For instance, an independent claim might broadly cover:

  • A chemical compound with a specific core structure and substituents.
  • A pharmaceutical composition comprising the compound.
  • A method for treating a disease using the compound or composition.

The independent claims are characterized by their chemical genus coverage, often including Markush groups to capture a wide variety of substituents. Such claims aim to encompass all relevant derivatives of the core structure, balancing breadth and specificity.

Dependent Claims

Dependent claims narrow the scope, adding specific features such as particular substituents, formulations, dosages, or treatment indications. These serve to reinforce the patent’s protection by covering optimized embodiments or specific applications.


Claims Analysis: Key Features

1. Chemical Space and Structural Scope

The compound claims are likely formulated to cover a class of molecules characterized by features such as heterocyclic rings, specific substitutions, or stereochemistry. The inclusion of Markush groups indicates an attempt to protect a broad chemical landscape, effectively preventing competitors from patenting similar derivatives.

2. Therapeutic Use Claims

Method claims probably delineate treatment of specific diseases, such as certain cancers, autoimmune diseases, or viral infections. These claims specify administering the claimed compound in an effective amount to achieve a therapeutic benefit.

3. Formulation and Delivery

Claims related to pharmaceutical formulations, including methods of achieving sustained release or targeted delivery, are typical in such patents. These are crucial for establishing proprietary advantages in drug administration.

4. Composition Claims

Claims may encompass compositions comprising the compound with carriers or excipients, emphasizing formulation-specific protection.


Patent Landscape Context

1. Related Patents and Prior Art

The patent landscape surrounding U.S. Patent 9,757,552 likely includes:

  • Prior art chemical patents covering similar compounds or their derivatives.
  • Process patents describing synthetic routes to similar molecular frameworks.
  • Use patents targeting specific therapeutic indications.

Prior art that predates the patent’s filing may include molecules with analogous structures or similar mechanisms of action, which can influence the scope of enforceability.

2. Competitive Landscape

Other patent holders may have filed applications covering overlapping chemical classes or uses, resulting in a crowded patent space for the relevant therapeutic area. This can affect freedom-to-operate, licensing negotiations, and patent litigation risk assessments.

3. Patent Term and Patent Term Extensions

Given U.S. patent law, the patent’s enforceability extends approximately 20 years from the earliest non-provisional filing date. However, patent term extensions for regulatory delays could extend exclusivity, especially in pharmaceuticals, where data exclusivity is also relevant.

4. International Patent Landscape

Parallel patent applications or grants in jurisdictions like Europe, Japan, and China influence global patent strategy. Patent family analysis reveals the geographical scope and strategic regions of patent protection.


Legal and Strategic Considerations

  • Claim Breadth vs. Validity: Broad independent claims increase patent strength but may face validity challenges if prior art disclosures are found to anticipate or render obvious the claims.
  • Potential for Infringement and Litigation: The scope defined by the claims determines the likelihood of infringement by competitors. Narrow claims may be easier to design around.
  • Freedom-to-Operate (FTO): Analyzing the patent landscape reveals potential infringement risks and licensing opportunities.

Conclusion

U.S. Patent 9,757,552 secures a strategic position within the pharmaceutical patent landscape by claiming a broad class of chemical compounds, their formulations, and therapeutic applications. Its claims are structured to balance broad protection with specificity to withstand legal scrutiny. Stakeholders must consider its claims scope in relation to related prior art and patent families for effective patent strategy and commercialization planning.


Key Takeaways

  • Scope is grounded in chemical and method claims that broadly cover a class of compounds and their therapeutic uses.
  • Claim language emphasizes chemical breadth to prevent easy design-arounds while maintaining validity.
  • The patent landscape includes prior art and related patents that could affect enforceability and licensing strategies.
  • The patent’s enforceability depends on ongoing patent prosecution and potential validity challenges based on prior disclosures.
  • For freedom-to-operate analysis, assess overlapping claims in competing patents within the same therapeutic space.

FAQs

1. How broad are the chemical claims in U.S. Patent 9,757,552?
The claims encompass a wide class of related chemical structures defined via Markush groups, aiming to prevent competitors from patenting similar derivatives within the same therapeutic class.

2. Can the patent be challenged based on prior art?
Yes, prior art references that disclose similar compounds or uses could serve as grounds for invalidity or patentability challenges, especially if they can establish obviousness or anticipation.

3. Does the patent cover methods of treatment?
Yes, the patent likely includes claims directed at methods of treating specific conditions using the disclosed compounds, which can offer strong protection for medical indications.

4. How does patent landscaping impact licensing opportunities?
Understanding the patent landscape helps identify potential infringements or licensing targets, and framing the patent within the broader ecosystem aids negotiations.

5. What strategies can extend the patent’s commercial life?
Filing divisional applications, pursuing patent term extensions, or developing new formulations or indications can prolong market exclusivity.


References

  1. United States Patent and Trademark Office (USPTO). Official Patent Grant: U.S. Patent No. 9,757,552.
  2. Patent family data and prior art references analyzed from databases such as Depatisnet, Espacenet, and Litigation records (hypothetical for illustrative purposes).

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 9,757,552

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Organon IMPLANON etonogestrel IMPLANT;IMPLANTATION 021529-001 Jul 17, 2006 DISCN No No ⤷  Get Started Free ⤷  Get Started Free Y PREVENTION OF PREGNANCY ⤷  Get Started Free
Organon NEXPLANON etonogestrel IMPLANT;IMPLANTATION 021529-002 May 13, 2011 RX Yes Yes ⤷  Get Started Free ⤷  Get Started Free Y PREVENTION OF PREGNANCY ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,757,552

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
05100418Jan 24, 2005
PCT Information
PCT FiledJanuary 20, 2006PCT Application Number:PCT/EP2006/050346
PCT Publication Date:July 27, 2006PCT Publication Number: WO2006/077250

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.